Total: 5 projects
GD33-199-301 Genzyme Study (2005 – 2008)
Title: A Randomized, Parallel, Open-Label Study to Compare Once Per Day Sevelamer Hydrochloride Table Dosing with Three Times Per Day Sevelamer Hydrochloride Tablet Dosing in Chronic Kidney Disease Patients on Hemodialysis.
CERA ML20336 Time and Motion Study (2006 – 2008)
Title: entitled “A prospective, randomized, open-lable, multi-center, pharmacoeconomic evaluation (Time and Motion) comparing RO0503821 to epoetin alfa in patients with chronic kidney disease (CKD) stage V on dialysis”.
Emerald Afdfymax-12 (2006 – 2008)
Title: entitled “A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of AF37702 Injection for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated with Epoetin alfa.”
Pearl Affymax-11 (2006 – 2008)
Title: entitled “A Phase 3, Randomized, Active-Controlled, Open-label, Multi-center Study of the Safety and Efficacy of AF37702 Injection for the Correction of Anemia in Patients with Chronic Renal Failure (CRF) not on Dialysis and not on Erythropoiesis Stimulation Agent (ESA) Treatment.”
Novartis CERL080AUS67 (2008 – 2009)
Title: entitled “ A multicenter, randomized, double blind, double dummy controlled study to assess the tolerability of an increased dose of myfortic® after conversion from CellCept® in renal transplant recipients who required CellCept® dose reductions due to gastrointestinal symptoms.”